New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body

Journal of Biomedical Materials Research

Volumn 47, Issue 2, 1999, Pages 189-197

  Bruining, Monique J ^a   Edelbroek Hoogendoorn, Petra S ^b   Blaauwgeers, Harriët G T ^b   Mooy, Cornelia M ^c   Hendrikse, Fred H ^b   Koole, Leo H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biodegradable biomaterials; Crosslinked hydrogels; Intraocular drug delivery; Photopolymerization

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED DRUG DELIVERY; CROSSLINKING; HYDROGELS; HYDROLYSIS; PHOTOPOLYMERIZATION;

CROSSLINKED HYDROGELS; POLY N-VINYLPYRROLIDINONE;

BIOMATERIALS;

GANCICLOVIR; POVIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; HYDROGEL; HYDROLYSIS; NONHUMAN; PHAGOCYTOSIS; RABBIT; SYNTHESIS; VITREOUS BODY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; PYRROLES; RABBITS; VINYL COMPOUNDS; VITREOUS BODY;

EID: 0032819608     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199911)47:2<189::AID-JBM8>3.0.CO;2-M     Document Type: Article

References (20)

1. Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HJ. Use of an intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 1987;103:17-23.
2. Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour H, Jr. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results. Ophthalmology 1989; 96:367-374.
3. Cochereau MI, Lehoang P, Lautier FM, Zazoun L, Marcel P, Robinet M, Matheron S, Katlama C, Gharakhanian S, Rozenbaum W. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1991;98:1348-1353.
4. Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, Chew EY, Ashton P, Davis MD, Nussenblatt RB. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994;112: 1531-1539.
5. Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol 1993;111:223-227.
6. Kunou N, Ogura Y, Hashizoe M, Honda Y, Hyon SH, Ikada Y. Controlled intraocular delivery of ganciclovir with use of biodegradable scierai implants in rabbits. J Controlled Release 1995;37:143-150.
7. Hashizoe M, Ogura Y, Takanashi T, Kunou N, Honda Y, Ikada Y. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits. Current Eye Res 1997;16:633-639.
8. Kimura H, Ogura Y, Hashizoe M, Nishiwaki N, Honda Y, Ikada Y. A new vitreal drug delivery system with an implantable biodegradable polymer device. Invest Ophthalmol Visual Sci 1994;35:2815-2819.
9. Veloso AAS, Herrero-Vanrell R, Refojo MF. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Invest Ophthalmol Visual Sci 1997;38:665-675.
10. Moriteira T, Ogura Y, Honda Y, Wada R, Hyon S, Ikada Y. Microspheres of biodegradable polymer as a drug delivery system in the vitreous. Invest Ophthalmol Visual Sci 1991;32: 1785-1790.
11. Khoobehi B, Stradtman MO, Peyman GA, Aly OM. Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection. Ophthalmol Surg 1991;22: 175-180.
12. Peyman GA, Conway M, Khoobehi B, Soike K. Clearance of microspheres entrapped 5-fluorouracil and cytosine arabinoside from the vitreous in primates. Int Ophthalmol 1992;16: 109-113.
13. Giordano GG, Chevez-Barrios P, Refojo M, Garcia CA. Biodegradation and tissue reaction of intravitreous biodegradable poly(D,L-lactic-co-glycolic) acid microspheres. Current Eye Res 1995;14:761-768.
14. Hong Y, Chirila TV, Cuypers MJH, Constable IJ. Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: physical selection. J Biomater Appl 1996;11:135-181.
15. Hong Y, Chirila TV, Vijayasekaran S, Shen W, Lou X, Dalton PD. Biodégradation in vitro and retention in the rabbit eye of crosslinked poly (1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res 1998;41:650-659.
16. Chirila TV, Constable IJ, Hong Y, Vijayasekaran S, Humphrey MF, Dalton PD, Tahija SG, Maley MAL, Cuypers MJH, Sharp C, Moore SR, Davies MJ. Synthetic hydrogel as an artificial vitreous body: a one-year animal study of its effect on the retina. Cells Mater 1995;5:83-96.
17. Hong Y, Chirila TV, Vijayasekaran S, Davies MJ, Maley MAL. In vitro cytotoxicity assay of synthetic hydrogels as potential vitreous substitutes. In Vitro Toxicol 1996;9:73-82.
18. Vijayasekaran S, Chirila TV, Hong Y, Tahija SG, Dalton PD, Constable IJ, McAllister IL. Poly(1-vinyl-2-pyrrolidinone) hydrogels as vitreous substitutes: histopathological evaluation in the animal eye. J Biomater Sci Polym Ed 1996;7:685-696.
19. Hong Y, Chirila TV, Vijayasekaran S, Dalton PD, Tahija SG, Cuijpers MJH, Constable IJ. Crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogels as a vitreous substitute. J Biomed Mater Res 1996;30:441-448.
20. Teranishi K, Nakao H, Komoda A, Hisamatsu M, Yamada T. One-step synthesis of novel carbonates: alkoxymethyl carbonates from alcohols and chloromethyl alkyl ethers using silver carbonate. Synthesis 1995;176-180.